Hyper-fractionated radiotherapy as a bridging strategy to enhance CAR-T efficacy by regulating T-cell co-stimulatory molecules in relapsed/refractory diffuse large B-cell lymphoma

BackgroundBridging therapy can prevent patients from disease progression while waiting for CAR-T cell preparation. Hyper-fractionated radiotherapy can achieve an effective target dose within a short period, minimize radiation damage, and may modify immune environment compared to conventional radioth...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Jing Ruan, Daobin Zhou, Yan Zhang, Danqing Zhao, Chong Wei, Ke Hu, Fuquan Zhang, Xiaorong Hou, Wei Zhang
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Frontiers Media S.A. 2024-12-01
Sarja:	Frontiers in Immunology
Aiheet:	hyper-fractionated radiotherapy DLBCL CAR-T bridging therapy T-cell co-stimulatory molecules
Linkit:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1481080/full
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!